Thomas G Graeber

Title: Thomas G Graeber: Innovator in Melanoma Treatment and Microfluidic Technology

Introduction

Thomas G Graeber is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the fields of oncology and microfluidics, holding a total of 2 patents. His work focuses on developing innovative methods for treating melanoma and enhancing small sample analysis through advanced technology.

Latest Patents

One of Graeber's latest patents is titled "Methods and compositions for treating melanoma." This patent presents a novel therapeutic approach for patients diagnosed with melanoma, particularly those resistant to existing therapies. The method involves administering a composition that includes a ferroptosis-inducing agent or other dedifferentiated melanoma-targeting agents.

Another significant patent is the "Integrated microfluidic radioassay and imaging platform for small sample analysis." This invention describes an immunocapture-based in vitro kinase assay on a polydimethylsiloxane (PDMS) microfluidics platform. It can accurately measure kinase activity from as few as 3,000 cells. The platform utilizes a solid-state beta-particle camera for real-time quantitative detection, making it a valuable tool for analyzing patient samples.

Career Highlights

Graeber is affiliated with the University of California, where he continues to advance research in his areas of expertise. His innovative work has the potential to significantly impact cancer treatment and diagnostic methods.

Collaborations

Some of his notable coworkers include Hsian-Rong Tseng and Arion F Hadjioannou (Chatziioannou). Their collaborative efforts contribute to the advancement of research and technology in their respective fields.

Conclusion

Thomas G Graeber is a distinguished inventor whose work in melanoma treatment and microfluidic technology showcases his commitment to innovation. His contributions are paving the way for new therapeutic methods and diagnostic tools that can improve patient outcomes.